Inside-Out Gelation for Biocompatible Hydrogel Microbeads

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for fabricating cell-containing hydrogel microbeads are limited to alginate or agarose polymers, which are not desirable for cellular health or function, and other superior hydrogel materials cannot be prepared as spherical microbeads due to their specific gelation mechanisms.

Innovation Solution

An inside-out gelation process is used to create core/shell microparticles with a biocompatible hydrogel precursor solution and a divalent cation, encapsulated in an alginate shell, which is then removed to yield self-sustaining hydrogel microbeads, allowing for the use of non-alginate hydrogel materials.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If alginate or agarose polymers are used to fabricate microbeads, then the gelation mechanism is simple and spherical microbeads can be formed, but the materials are not desirable for cellular health or function

Engineering Contradiction:
Improvegelation mechanism simplicityVSAvoidcellular health and function
Core Design Contradiction:
Ease of manufactureVSObject-affected harmful factors

Solution Approach 1:

The microbead structure is segmented into two distinct parts: a temporary alginate shell and a permanent non-alginate hydrogel core. The alginate shell provides ease of manufacture and spherical formation, while the hydrogel core provides biocompatibility for cellular health. This segmentation allows each material to fulfill its optimal function without compromise.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The alginate shell acts as an intermediary or temporary mold that facilitates the formation of the hydrogel core. It provides the spherical structure and protective environment during fabrication, then serves as a removable template that allows the hydrogel core to be released as a self-sustaining microbead. The alginate serves as a mediating structure between the fabrication process and the final biocompatible product.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Object-affected harmful factors

If superior non-alginate hydrogel materials are used, then cellular health and function are improved, but they cannot be prepared as spherical microbeads due to specific gelation mechanisms

Engineering Contradiction:
Improvecellular health and functionVSAvoidspherical microbead formation
Core Design Contradiction:
Object-affected harmful factorsVSEase of manufacture

Solution Approach 1:

Instead of forming the hydrogel shell first and then filling the core, the process is inverted: a temporary alginate shell is formed first, then the hydrogel precursor solution is injected into the core, and finally the hydrogel crosslinks within the alginate mold. This inversion allows the superior hydrogel materials to be processed into spherical microbeads by reversing the traditional formation sequence.

Inventive Principle:
Principle #13The other way round (Inversion)

Solution Approach 2:

The alginate shell serves as an intermediary mold that enables the formation of spherical microbeads from non-alginate hydrogel materials. The alginate provides the necessary spherical geometry and structural support during fabrication, then is removed to leave the self-sustaining hydrogel microbead. This intermediary approach bridges the gap between material superiority and manufacturability.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Ease of manufacture

If a temporary alginate shell is used during fabrication, then spherical microbead formation is enabled, but an additional removal step is required

Engineering Contradiction:
Improvespherical microbead formationVSAvoidfabrication process steps
Core Design Contradiction:
Ease of manufactureVSProductivity

Solution Approach 1:

The alginate shell is designed as a temporary, disposable structure that serves its purpose during fabrication and is then discarded. It is not intended for long-term use but rather as a single-use mold that enables the creation of the permanent hydrogel microbead. This approach accepts the additional removal step as a necessary trade-off for achieving spherical formation with superior materials.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The alginate shell is discarded after serving its temporary function as a mold during fabrication. The process involves forming the shell, filling the core, allowing hydrogel crosslinking, then removing and discarding the alginate shell to reveal the finished hydrogel microbead. This discarding approach simplifies the overall process by using a removable template rather than a permanent composite structure.

Inventive Principle:
Principle #34Discarding and recovering

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method enables the production of biocompatible, customizable hydrogel microbeads that support cellular health and function, improving biocompatibility and control over mechanical and degradation properties, suitable for various applications in regenerative medicine.

Implementation Method 1

The hydrogel precursor compound in the liquid core is crosslinked to yield core/shell crosslinked microparticles

Methodology Applied
Scientific EffectCrosslinking: Chemical Bonding

Implementation Method 2

The temporary alginate shell is then removed to yield self-sustaining hydrogel microbeads

Methodology Applied
Scientific EffectChelation: Chemical Bonding

Data Source

PatentEP3151809B1Microencapsulation technique and products thereof
Publication Date: 2021.02.24 LIKARDA LLC
  • EP3151809B1 patent drawingFigure 1~2
  • EP3151809B1 patent drawingFigure 3~4
  • EP3151809B1 patent drawingFigure 5~6

AI summary

Inside-out gelation process to generate hydrogel microcapsules (aka microbeads). Methods of encapsulating biological material in the microbead 3-dimensional hydrogel matrix are described herein. The process generally comprises formation of a mixture of a hydrogel precursor compound, an optional biological material, and a divalent cation. The mixture is then combined with alginate, to generate an alginate shell around droplets of the mixture, followed by gelation of the hydrogel precursor core, and removal of the temporary alginate shell to yield self-sustaining microbeads.